Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced GIST
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib
J. Clin. Oncol 2020 Aug 17;[EPub Ahead of Print], F Janku, AR Abdul Razak, P Chi, MC Heinrich, M von Mehren, RL Jones, K Ganjoo, J Trent, H Gelderblom, N Somaiah, S Hu, O Rosen, Y Su, R Ruiz-Soto, M Gordon, S GeorgeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.